Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury

Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury

Cisplatin (CDDP) is a widely used anticancer drug, but acute kidney injury (AKI) is one of the most important dose-limiting factors. Trace metal elements are present in various concentrations in the body and play an important role in maintaining normal vital functions. However, the relationship betw...

Full description

Bibliographic Details
Main Authors: Yuko Yamamoto, Yuji Hotta, Natsumi Tomita, Aya Naiki-Ito, Ayae Kitagawa, Urara Kuboshiki, Tamaki Hagita, Misuzu Noda, Akimasa Sanagawa, Tomoya Kataoka, Masahiro Kondo, Yoko Furukawa-Hibi, Satoru Takahashi, Kazunori Kimura
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Biochemistry and Biophysics Reports
Subjects:
Cisplatin
Acute kidney injury
Urine
Zinc
Manganese
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580823000031

Similar Items

Similar Items